评估 Avipattikar churna 与 Chitrakadi kwath 在治疗 Amlapitta(胃酸过多)方面的疗效 - 一项试点研究

Pub Date : 2024-07-10 DOI:10.47552/ijam.v15i2.4587
I. Gaikwad, Sadhana Misar Wajpeyi
{"title":"评估 Avipattikar churna 与 Chitrakadi kwath 在治疗 Amlapitta(胃酸过多)方面的疗效 - 一项试点研究","authors":"I. Gaikwad, Sadhana Misar Wajpeyi","doi":"10.47552/ijam.v15i2.4587","DOIUrl":null,"url":null,"abstract":"Amlapitta is a condition characterised by the predominance of Pitta and is associated with the Annavaha and Purishvaha srotas. It manifests as a result of imbalances in Mandagni (weakened digestive fire) and the presence of Ama (undigested or improperly metabolized substances). The prevalence rate of Amlapitta in India is 38.1%. Considering the similarities in etiopathogenesis, it can be correlated with Hyperacidity in Modern Science. Aim and Objectives: To evaluate the efficacy of Avipattikar churna versus Chitrakadi kwath in the management of Amlapitta (Hyperacidity). Methodology: An Interventional Study was conducted among 30 patients between the ages of 20 and 60 of either sex who had symptoms of Tikta Amlodgar (sour and bitter irructation), Hrit-kanthadaha (burning in heart and throat), Udarashool (epigastric pain) and Utklesha (nausea),  and Aruchi (anorexia). Group A was given Aipattikar Churna; Group B was given Chitrakadi Kwath. Subjective Parameters were assessed in both groups on the 0th, 7th, and 15th days, and comparison was done by statistical analysis. Observation and Discussion: Both interventions proved effective, showcasing strengths in addressing distinct subjective parameters. Conclusion: Both drugs demonstrated high effectiveness in the study. Group A exhibited significant improvements across all subjective parameters, except Udarshoola (Abdominal pain). On the other hand, Group B displayed notable results in all subjective parameters, except for Utklesha and Aruchi. In conclusion, both groups were significant.","PeriodicalId":0,"journal":{"name":"","volume":"43 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of efficacy of Avipattikar churna versus Chitrakadi kwath in the management of Amlapitta (Hyperacidity) - A pilot study\",\"authors\":\"I. Gaikwad, Sadhana Misar Wajpeyi\",\"doi\":\"10.47552/ijam.v15i2.4587\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Amlapitta is a condition characterised by the predominance of Pitta and is associated with the Annavaha and Purishvaha srotas. It manifests as a result of imbalances in Mandagni (weakened digestive fire) and the presence of Ama (undigested or improperly metabolized substances). The prevalence rate of Amlapitta in India is 38.1%. Considering the similarities in etiopathogenesis, it can be correlated with Hyperacidity in Modern Science. Aim and Objectives: To evaluate the efficacy of Avipattikar churna versus Chitrakadi kwath in the management of Amlapitta (Hyperacidity). Methodology: An Interventional Study was conducted among 30 patients between the ages of 20 and 60 of either sex who had symptoms of Tikta Amlodgar (sour and bitter irructation), Hrit-kanthadaha (burning in heart and throat), Udarashool (epigastric pain) and Utklesha (nausea),  and Aruchi (anorexia). Group A was given Aipattikar Churna; Group B was given Chitrakadi Kwath. Subjective Parameters were assessed in both groups on the 0th, 7th, and 15th days, and comparison was done by statistical analysis. Observation and Discussion: Both interventions proved effective, showcasing strengths in addressing distinct subjective parameters. Conclusion: Both drugs demonstrated high effectiveness in the study. Group A exhibited significant improvements across all subjective parameters, except Udarshoola (Abdominal pain). On the other hand, Group B displayed notable results in all subjective parameters, except for Utklesha and Aruchi. In conclusion, both groups were significant.\",\"PeriodicalId\":0,\"journal\":{\"name\":\"\",\"volume\":\"43 11\",\"pages\":\"\"},\"PeriodicalIF\":0.0,\"publicationDate\":\"2024-07-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47552/ijam.v15i2.4587\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47552/ijam.v15i2.4587","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

阿姆拉皮塔(Amlapitta)是一种以皮塔(Pitta)为主的病症,与安纳瓦哈(Annavaha)和普里什瓦哈(Purishvaha)两种体质有关。它表现为 Mandagni(消化系统火力减弱)失衡和 Ama(未消化或代谢不当的物质)的存在。在印度,Amlapitta 的发病率为 38.1%。考虑到发病机理的相似性,现代科学可将其与胃酸过多联系起来。目的和目标评估 Avipattikar churna 与 Chitrakadi kwath 在治疗 Amlapitta(胃酸过多)方面的疗效。研究方法:对 30 名年龄在 20 岁至 60 岁之间、有 Tikta Amlodgar(酸苦虹吸)、Hrit-kanthadaha(心脏和喉咙灼热)、Udarashool(上腹痛)、Utklesha(恶心)和 Aruchi(厌食)症状的男女患者进行干预研究。A 组服用 Aipattikar Churna;B 组服用 Chitrakadi Kwath。在第 0 天、第 7 天和第 15 天对两组的主观参数进行评估,并通过统计分析进行比较。观察和讨论:事实证明,两种干预方法都很有效,在解决不同的主观参数方面都有优势。结论:两种药物在研究中都表现出很高的有效性。A 组除 Udarshoola(腹痛)外,所有主观指标均有明显改善。另一方面,B 组除 Utklesha 和 Aruchi 外,在所有主观参数方面都有显著效果。总之,两组的效果都很明显。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
Evaluation of efficacy of Avipattikar churna versus Chitrakadi kwath in the management of Amlapitta (Hyperacidity) - A pilot study
Amlapitta is a condition characterised by the predominance of Pitta and is associated with the Annavaha and Purishvaha srotas. It manifests as a result of imbalances in Mandagni (weakened digestive fire) and the presence of Ama (undigested or improperly metabolized substances). The prevalence rate of Amlapitta in India is 38.1%. Considering the similarities in etiopathogenesis, it can be correlated with Hyperacidity in Modern Science. Aim and Objectives: To evaluate the efficacy of Avipattikar churna versus Chitrakadi kwath in the management of Amlapitta (Hyperacidity). Methodology: An Interventional Study was conducted among 30 patients between the ages of 20 and 60 of either sex who had symptoms of Tikta Amlodgar (sour and bitter irructation), Hrit-kanthadaha (burning in heart and throat), Udarashool (epigastric pain) and Utklesha (nausea),  and Aruchi (anorexia). Group A was given Aipattikar Churna; Group B was given Chitrakadi Kwath. Subjective Parameters were assessed in both groups on the 0th, 7th, and 15th days, and comparison was done by statistical analysis. Observation and Discussion: Both interventions proved effective, showcasing strengths in addressing distinct subjective parameters. Conclusion: Both drugs demonstrated high effectiveness in the study. Group A exhibited significant improvements across all subjective parameters, except Udarshoola (Abdominal pain). On the other hand, Group B displayed notable results in all subjective parameters, except for Utklesha and Aruchi. In conclusion, both groups were significant.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1